Cardax Initiates Monkey Study to Compare Bioavailability of Patented Consumer Health Product Candidate CDX-085 to Microalgal Astaxanthin
Business News
HONOLULU--(BUSINESS WIRE)--Cardax initiated a monkey study to compare the bioavailability of CDX-085, its patented product candidate, to microalgal astaxanthin, the predominate astaxanthin consumer health form on the market.
Cardax-Logo-Large.jpg
< Prev
Next >